WithdrawnNCT01416220
Lithium Versus Paroxetine in Major Depression
Medication studyAges 18+Canada
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
- Listed locations
- HalifaxSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 2011
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Nova Scotia Health Authority
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- Over 18 Years
- Official registry ID
- NCT01416220
- Official title
Show the full official title
A Randomized, Open-label, Trial of Lithium Versus Paroxetine in Subjects With Major Depression Who Have a Family History of Bipolar Disorder or Completed Suicide
Recruitment & locations
WithdrawnHalifax
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Nova Scotia Health Authority.
Does this study involve medication?
Yes. The study involves medication, including lithium and Paroxetine.
Who can participate?
This study is for people with depression. Listed age limits: from 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as withdrawn.
